Loading...
•
Jun 30, 2022
Pediatrix Q2 2022 Earnings Report
Pediatrix reported earnings, reflecting modest volume growth and operating efficiency, with a return to its core brand.
Key Takeaways
Pediatrix Medical Group reported a net revenue of $486 million for the second quarter of 2022, with earnings from continuing operations at $0.36 per share and Adjusted EPS at $0.47. The company's revenue growth was driven by net acquisition activity, slightly offset by a same-unit revenue decrease of 1.3 percent.
Net revenue reached $486 million.
Earnings from continuing operations were $0.36 per share.
Adjusted EPS from continuing operations was $0.47.
Adjusted EBITDA was $66 million.
Forward Guidance
Pediatrix anticipates that its 2022 Adjusted EBITDA will be in a range of $260 million to $270 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...